Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Virology|May 5, 2009
Enhanced papillomavirus-like particle production in insect cellsTilo Senger, Lysann Schädlich, Lutz Gissmann, et al.Antiviral Therapy|February 2, 2012
New approaches to prophylactic human papillomavirus vaccines for cervical cancer preventionElizabeth D Gersch, Lutz Gissmann, Robert L GarceaAntiviral Therapy|October 1, 2004
Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitolEva-Jasmin Freyschmidt, Angel Alonso, Gunther Hartmann, et al.Vaccine|September 5, 2006
Chapter 1: HPV in the etiology of human cancerNubia Muñoz, Xavier Castellsagué, Amy Berrington de González, et al.Vaccine|May 9, 2007
Prophylactic DNA immunization against multiple papillomavirus typesMaja Gasparić, Ivonne Rubio, Nadja Thönes, et al.Vaccine|January 5, 2005
Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 miceThorsten Steinberg, Peter Ohlschläger, Peter Sehr, et al.Vaccine|February 4, 2006
Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levelsKerstin Dell, Robert Koesters, Michael Linnebacher, et al.Gut Pathogens|May 1, 2014
Helicobacter pylori antibody patterns in Germany: a cross-sectional population studyAngelika Michel, Michael Pawlita, Heiner Boeing, et al.Journal of Virology|October 2, 2009
Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomavirusesTilo Senger, Maria R Becker, Lysann Schädlich, et al.Vaccine|January 29, 2009
Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicityLysann Schädlich, Tilo Senger, Carsten J Kirschning, et al.Pageof 7